Faricimab phase 3 DME trial significance of personalized treatment intervals (PTI) regime for future DME trials.
Ashish SharmaNilesh KumarNikulaa ParachuriDhatri KaranamBaruch D KuppermannFrancesco Maria BandelloCarl D RegilloPublished in: Eye (London, England) (2021)
Keyphrases